Please assess the completion status of the following clinical trial:

Trial Title: LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung Cancer

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Persons with non-small cell lung cancer (NSCLC) who have undergone surgical resection, via a lobectomy, pneumonectomy, or wedge resection and currently have no evidence of disease (NED).~* Persons with head/neck squamous cell cancer who have undergone radical head and/or neck resection and who currently have NED.~* Persons with severe chronic, obstructive, pulmonary disease as evidenced by pulmonary function abnormalities: i.e. FEV1 \< 50%predicted; RV \> 200% predicted and/or DLCO \< 40% predicted.~Exclusion Criteria:~* Persons with uncontrolled hypertension (systolic pressure \>200mmHG, diastolic pressure \>120 mm HG)~* Persons with unstable angina.~* Persons with known or suspected pneumonia.~* Persons with acute bronchitis within one month of the procedure.~* Persons who have received neoadjuvant or adjuvant chemo- or radio-therapy within the past six months.~* Persons with white blood count (WBC) less than 2000 or greater than 20,000 and/or platelet count less than 50,000.~* Persons with any known bleeding dyscrasia.~* Persons who have received fluorescent photosensitizing drugs such as Photofrin within one month of the procedure.~* Persons with a known allergic reaction to topical xylocaine (lidocaine).~* Persons who have received or are on chemopreventive drugs (i.e. retinoic acid) within one month of the procedure.~* Persons who have received ionizing radiation to the chest within six months of the procedure.~* Persons who have received systemic cytotoxic chemotherapeutic agents within the past six months.~* Persons who are pregnant or nursing. All women of childbearing potential must have a negative serum pregnancy test prior to enrollment.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).